Main Topic Area
News
1 - 3 of 3
- Somaxon Pharmaceuticals Reports Positive Results From A Pilot Phase 2 Study Of Oral Nalmefene In Smoking Cessation
MedicalNewsToday - Thu, 27 Jul 2006 06:00 EST
- Drug may curb gambling addiction
MSNBC - Wed, 08 Mar 2006 08:56 EST
- Drug may curb pathological gambling
Reuters - Wed, 08 Mar 2006 07:25 EST
Clinical Trials
1 - 2 of 2
- Nalmefene Gambling Study
ClinicalTrials.gov Identifier: NCT00132119 - Active, not recruiting
Pathological Gambling
- Nalmefene Smoking Cessation Study
ClinicalTrials.gov Identifier: NCT00202696 - Active, not recruiting
Smoking Cessation

Not Signed In -

